ISAB — Inhalation Sciences Sweden AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK47.63m
- SEK40.78m
- SEK17.50m
Annual cashflow statement for Inhalation Sciences Sweden AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.9 | -8.74 | -16.6 | -12 | -3.76 |
| Depreciation | |||||
| Non-Cash Items | 0 | 0.614 | 0.114 | — | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.43 | 1.81 | -3.46 | -1.16 | -1.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -8.78 | -5.14 | -18.7 | -12 | -3.74 |
| Capital Expenditures | -2.74 | -0.865 | -0.197 | -0.04 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -2.74 | -0.865 | -0.197 | -0.04 | 0 |
| Financing Cash Flow Items | — | — | -1.59 | 0 | -3.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14 | 9.26 | 25.3 | -0.509 | 9.73 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.52 | 3.25 | 6.35 | -12.6 | 5.99 |